e.g. Tata motors, Reliance MF, 500570

Marksans Pharma Ltd. - Research Center

524404 MARKSANS Group (A) BSE data
 
Back to Company Page
Results:

Quarterly results in brief

(Rs crore)
Sep' 25 Jun' 25 Mar' 25 Dec' 24 Sep' 24
Sales 320.44 319.73 299.36 311.87 308.63
Operating profit 72.08 70.05 50.57 59.94 52.27
Interest 0.32 0.30 0.31 0.30 0.28
Gross profit 129.95 71.76 58.08 82.14 83.35
EPS (Rs) 2.20 1.06 0.83 1.22 1.39

Quarterly  results in details

Sep' 25 Jun' 25 Mar' 25 Dec' 24 Sep' 24
Other income 58.19 2.01 7.82 22.51 31.36
Stock adjustment -2.17 -3.29 2.30 5.63 -0.55
Raw material 146.66 145.28 145.06 141.27 134.73
Power and fuel - - - - -
Employee expenses 28.46 27.90 28.82 25.75 23.91
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 75.42 79.79 72.61 79.27 98.26
Provisions made - - - - -
Depreciation 8.46 8.19 8.18 7.42 7.02
Taxation 21.69 15.52 12.31 19.26 13.13
Net profit / loss 99.81 48.06 37.59 55.46 63.20
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 45.32 45.32 45.32 45.32 45.32
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 22.49 21.91 16.89 19.22 16.94
GPM (%) 34.32 22.30 18.91 24.57 24.52
NPM (%) 26.36 14.94 12.24 16.59 18.59
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback